Primary Immune Deficiency Disorders (PIDD)
1 clinical trials · Condition
◉ Watch Primary Immune Deficiency Disorders (PIDD)
| Record | Firm | Date |
|---|---|---|
| Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD) (NCT00538915) | ADMA Biologics, Inc. | 2007-09-01 |
Track Primary Immune Deficiency Disorders (PIDD) automatically
Every clearance here is in the API, with alerts when new ones post.